NVS
Novartis AG ADRNYSEHEALTHCAREDRUG MANUFACTURERS - GENERAL
Key Statistics
Market Cap
$298.07B
P/E Ratio
21.60
EPS
$7.15
Beta
0.52
52W High
$165.43
52W Low
$101.60
50-Day MA
$156.44
200-Day MA
$134.93
Dividend Yield
3.13%
Profit Margin
24.70%
Forward P/E
17.12
PEG Ratio
2.68
About Novartis AG ADR
Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.
Fundamentals
| Revenue (TTM) | $56.67B |
| Gross Profit (TTM) | $43.05B |
| EBITDA | $23.47B |
| Operating Margin | 27.80% |
| Return on Equity | 30.80% |
| Return on Assets | 11.10% |
| Revenue/Share (TTM) | $29.23 |
| Book Value | $24.18 |
| Price-to-Book | 6.37 |
| Price-to-Sales (TTM) | 5.26 |
| EV/Revenue | 5.64 |
| EV/EBITDA | 14.02 |
| Quarterly Earnings Growth (YoY) | -11.60% |
| Quarterly Revenue Growth (YoY) | 2.20% |
| Shares Outstanding | $1.91B |
| Float | $1.82B |
| % Insiders | 0.00% |
| % Institutions | 7.11% |
Analyst Ratings
Consensus ($153.26 target)
2
Strong Buy2
Buy5
Hold2
SellData last updated: 4/9/2026